![](/wp-content/themes/yootheme/cache/e3/Georgia-e357a4f9.jpeg)
Local Cdiff information for Georgia
Georgia
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Georgia.
Local Cdiff information for Georgia
Georgia
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Georgia.
![](/wp-content/themes/yootheme/cache/e3/Georgia-e357a4f9.jpeg)
Providers
Nirja Mehta, MD, MS
Emory University Hospital Midtown Campus
550 Peachtree Street Northeast
Medical Office Tower, Fl 7
Atlanta, GA 30308
(404) 686-8114
Dr. Ravi Kamepalli, MD
Regional Infectious Diseases and Infusion Center, Inc.
505 Jenkins St
LaGrange, 30240
706-739-7789
FMT Provider: Yes
Dr. Colleen Kraft, MD Assistant Professor, Pathology & Laboratory Medicine
Emory Clinic at 1365 Clifton Road
1365 Clifton Road NE
Atlanta, 30322
404-686-8114
FMT Provider: Yes
Regulation
C. diff Infections
Total Reported Cases: 2203
Hospital Onset: 2203
Community Onset: Not reported
Related Deaths: Not reported
Available Reports
State Reporting Laws
Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
State Contact
Jeanne Negley, MBA
HAI Surveillance Program Director
Georgia Department of Community Health
Division of Public Health Acute Disease Epidemiology Section
2 Peachtree Street NW, #14-225
Atlanta, 30303
(404) 657-2593
(404) 657-7517
CLINICAL TRIALS
OpTION
Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
Gender: All
Age: 18 Years and older
ROAR
Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older
RESTORATiVE303
Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.